HealthQuad Fund-II round closes at $162 million

Healthcare venture capital HealthQuad has announced the closing of its second fund round at $162 million.

Healthcare venture capital HealthQuad has announced the closing of its second fund round at $162 million. This figure is 2.2 times bigger than the number anticipated at its launch.

This round was led by pharma giant MSD. With their Fund-II, HealthQuad plans to invest it in 10 to 15 private healthcare players in the Indian startup ecosystem. For this, they select such startups that help create a large social impact by using the technology to achieve high reach and scale.

Founded by Abrar Mir, Amit Varma and Charles-Antoine Janssen, it has been investing in Indian healthcare startups since 2016. They have invested in Ekincare, Stanplus, THB, Medikabazaar, Impactguru, Qure.ai and HealthifyMe amongst many others.

Their investor base includes Ackermans & van Haaren, Teachers Insurance and Annuity Association of America, Quilvest, HCL Corporation, Swedfund along with Small Industries Development Bank of India.

As much as $60 million has already been invested in various startups from HealthQuad Fund-II. The venture is backed by Quadria Capital and KOIS. In their first outing in 2017, they had raised Rs 75 crore, which was higher than the anticipated Rs 65 crores. 

India's startup scene is quite vibrant. Over 8000 Indian startups belong to the Healthtech category alone, making it a promising area to invest in.

Tags : #HealthQuad #AbrarMir #AmitVarma #Charles-AntoineJanssen #Ekincare #Qureai #HealthifyMe #THB #Impactguru #Stanplus #funding #fundingalert #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Antibiotics Are Not Always the Answer: Understanding Viral Infections and Responsible Medication UseJanuary 02, 2025
Medical Emergencies Are Above Rules: What This Delhi HC Verdict Means for YouJanuary 02, 2025
Is Your Uterus Safe? The Disturbing Trends in Women’s Health Across IndiaJanuary 02, 2025
India’s Pharma Industry Faces New Regulatory Storm: Will Drugmakers Adapt to Schedule M?January 02, 2025
From Vision to Value: Inside Dr. Agarwal Health Care’s Market-Dominating IPOJanuary 02, 2025
5 Ways to Help Relieve Constipation in Babies at HomeDecember 30, 2024
10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024